These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8243040

  • 21. In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.
    Jones RN.
    Drugs; 1988; 35 Suppl 7():17-26. PubMed ID: 3265377
    [Abstract] [Full Text] [Related]

  • 22. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)].
    Migueres ML, Ronco E, Guenounou M, Philippon A.
    Pathol Biol (Paris); 1989 May; 37(5):397-401. PubMed ID: 2674869
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
    WaKabongo M, Stucki ZN, Torbert DP, Olweny J.
    J Am Osteopath Assoc; 2005 Jan; 105(1):25-6. PubMed ID: 15710671
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus.
    Liu H, Lewis N.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):47-51. PubMed ID: 1563385
    [Abstract] [Full Text] [Related]

  • 29. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
    Prabhakaran K, Harris EB, Randhawa B, Adams LB, Williams DL, Hastings RC.
    Microbios; 1993 Jan; 76(309):251-61. PubMed ID: 8302203
    [Abstract] [Full Text] [Related]

  • 30. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
    Brumfitt W, Hamilton-Miller JM, Dixson S, Gargan RA, Gooding A.
    J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA, Vanderpool L, Wesselman J.
    J Burn Care Rehabil; 1985 Jun; 6(4):331-4. PubMed ID: 3879938
    [No Abstract] [Full Text] [Related]

  • 34. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG, Wittenberger R.
    Rev Infect Dis; 1986 Jun; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV.
    Diagn Microbiol Infect Dis; 1991 Apr; 14(1):75-7. PubMed ID: 1901536
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.